The FDA has announced plans to reconsider its approval process for gene therapies, following a recent petition from advocacy groups urging the agency to withdraw its approval of the use of antibiotics in livestock.[1248147][1247594] The move comes as UniQure prepares to submit its Huntington's disease treatment for FDA approval, despite previous opposition from former FDA officials.[1240208][1247594] Advocacy groups are also pushing the FDA to take action on the use of antibiotics in livestock, citing concerns over the development of antibiotic-resistant bacteria.[1248147]